Approval · Notice of Compliance 6822 · 2005
PROLASTIN: Notice of Compliance 6822
Issued May 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6822
- Date
- May 18, 2005
- Company
- Talecris Biotherapeutics, Inc.Clayton, North Carolina, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Alpha 1-antitrypsin replenisher
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLASTIN | 02204592 | — |
| PROLASTIN | 02204606 | Marketed |
Medicinal ingredients
- ALPHA1-PROTEINASE INHIBITOR (HUMAN) 500 MG per VIAL
- ALPHA1-PROTEINASE INHIBITOR (HUMAN) 1 G per VIAL